MESALAZINE ORAL (prescribe by brand)

Clinical Indication

Ulcerative colitis, Crohn's disease and paediatric colitis

Comments

Monitoring for paediatrics done by secondary care

Date of classification

September 2022

Yellow

Medicines initiated or recommended by a specialist service for prescribing in primary care which do not require initiation or ongoing oversight by the specialist. There are no specific paperwork requirements between provider organisations and a verbal request may be acceptable through advice and guidance as long enough information is provided so that the transfer of care is safe.